The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...

Novonesis leads in enzymes and biosolutions with strong growth, margins, and strategy, but valuation calls for patience. See ...

With Australian and US stocks more expensive than ever, fund managers are looking to Europe for the best growth opportunities ...